SCHEMBL21155351

SCHEMBL21155351

CNc1ncccc1COC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CASP3 P42574 2/20 0.40
SENP8 Q96LD8 2/20 0.40
SENP7 Q9BQF6 2/20 0.40
SENP6 Q9GZR1 2/20 0.40
MAPT P10636 4/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 5/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
NPC1 O15118 2/20 0.39
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1066057 0.89 CASP3 (0.40) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL1066058 0.88 HTT (0.40) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL12933217 0.81 BRD4 (0.36) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL24107506 0.78 ALDH1A1 (0.44) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL10752180 0.78 ALDH1A1 (0.49) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL23671634 0.77 FDPS (0.40) MAPTCYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL30753861 0.76 LATS1 (0.35) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL30753863 0.76 MEN1 (0.41) ALDH1A1MAPTCYP1A2CYP3A4CYP2C19
SCHEMBL30753862 0.76 LATS1 (0.35) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL23671633 0.76 FDPS (0.36) ALDH1A1MAPTCYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019136112-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE BRISTOL-MYERS SQUIBB COMPANY (US) 2019-07-11 WO disclosed